Kiniksa Pharmaceuticals Ltd (KNSA) earnings · rev $677.6M
These earnings events as JSON? API free 100/dayKiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
This KNSA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B.
When the next KNSA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 60.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full KNSA research stays on the stock page; the tape stays on the quote page.
KNSA earnings FAQ
What are KNSA's latest revenue and net income?
Latest cached Kiniksa Pharmaceuticals Ltd (KNSA) revenue for Dec 31, 2025 was $677.6M. Net income was $59.0M. Statements: https://lician.com/financials/knsa
What is KNSA's latest diluted EPS?
Latest cached Kiniksa Pharmaceuticals Ltd (KNSA) diluted EPS for Dec 31, 2025 was $0.75.
What period does the latest KNSA earnings print cover?
The latest cached Kiniksa Pharmaceuticals Ltd (KNSA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did KNSA revenue change from the prior cached period?
Cached Kiniksa Pharmaceuticals Ltd (KNSA) revenue was up 60.1% from $423.2M (Dec 31, 2024) to $677.6M (Dec 31, 2025). Statements: https://lician.com/financials/knsa
Where are KNSA earnings listed?
Cached earnings facts for Kiniksa Pharmaceuticals Ltd (KNSA) are listed at https://lician.com/earnings/knsa. Statements: https://lician.com/financials/knsa
Not investment advice.